IL17A and systemic lupus erythematosus: There were significant differences in expression of BTLA on stimulated Th17-cells between active and inactive SLE patients (CD3+CD8−CD69+IL-17A+: %BTLA, 64.4% ± 31.3% vs. 28.8% ± 23.1%, p = 0.039, Figure 3D).